Neurocrine Biosciences Aktie
101,60
EUR
+1,60
EUR
+1,60
%
107,22
USD
-3,71
USD
-3,34
%
Werbung
Neurocrine Biosciences Aktie Analyse
14.12.07 | Neurocrine Biosciences underperform | Bear Stearns Companies Inc. | |
14.12.07 | Neurocrine Biosciences sell | Piper Jaffray & Co. | |
14.12.07 | Neurocrine Biosciences underperform | Jefferies & Company Inc. | |
29.06.06 | Neurocrine Biosciences reduce | UBS | |
23.06.06 | Neurocrine Biosciences underweight | Morgan Stanley | |
23.06.06 | Neurocrine Biosciences sell | Citigroup | |
16.06.06 | Neurocrine Biosciences underperform | Leerink Swann | |
16.06.06 | Neurocrine Biosciences underperform | Robert W. Baird | |
Werbung
|
|||
16.06.06 | Neurocrine Biosciences Underperform | Leerink Swann | |
18.05.06 | Neurocrine Biosciences underperform | Jefferies & Co |
Werbung
Werbung